Journal of Biomaterials Applications

Journal of Biomaterials Applications is a peer-reviewed SAGE journal, issued in London, that reports the development, testing and clinical use of biomaterials. Technomic founded it in 1986, and its 2025 impact factor is 2.4.《生物材料应用杂志》是 SAGE 在伦敦发行的一份同行评审期刊，报道生物材料的研制、测试与临床应用。该刊由 Technomic 于 1986 年创办，2025 年影响因子为 2.4。

Scope

• Its own description calls the journal a fully peer reviewed international outlet for original research and review articles on biomaterials, and it names no single material family or clinical specialty as its subject.该刊的自我描述是一份国际性的完全同行评审刊物，发表生物材料方向的原创研究与综述，并未把题材限定在某一类材料或某一个临床专科。

• The statement goes on to say that the journal is devoted to new and emerging biomaterials technologies, the phrase the publisher uses to describe its subject.声明接着说，该刊致力于新兴的生物材料技术，这也是出版方描述其主题时使用的说法。

• Particular attention, the text adds, goes to applications under development at industrial biomedical research facilities and at polymer research facilities.文本补充说，重点之一是在工业生物医学研究机构与高分子研究机构中开发中的应用。

• Ongoing activity in academic laboratories forms a third strand, and the medical and applied clinical use of devices forms a fourth.学术实验室里的持续工作构成第三条线索，器械在医疗与实践临床中的使用构成第四条。

• Original findings on the biological compatibility of biomaterials are named as a core subject, and so are findings on incompatibility.生物相容性方面的原创发现被列为该刊的核心主题，不相容性方面的发现同样列入。

• That pairing puts host response and material failure on the same footing, since a material that provokes a reaction is studied as closely as one that does not.这一并列把宿主反应与材料失效放在同等位置，会引发反应的材料与不引发反应的材料受到同样的关注。

• Papers on implants for bone and teeth appear often, a natural consequence of the applied brief that the scope sets out.骨与牙植入物方向的论文出现频繁，这是收稿范围所设定的应用导向带来的自然结果。

• Degradable polyesters, polyurethanes and chitosan recur among the materials, usually with an eye on how fast they break down in the body.可降解聚酯、聚氨酯与壳聚糖是反复出现的材料，讨论多落在它们在体内降解的快慢上。

• Scaffolds for tissue engineering make up another large group, together with the hydrogels and porous ceramics used to carry cells.组织工程支架构成另一大类，用来承载细胞的水凝胶与多孔陶瓷同属其中。

• Drug delivery systems and controlled release carriers are covered, including microspheres and coatings that release an agent over weeks.药物递送系统与控释载体也在范围内，包括能在数周之内释放药物的微球与涂层。

• Surface modification and antimicrobial treatment draw attention, and the prevention of biofilm growth on implanted devices falls inside the same remit.表面改性与抗菌处理受到关注，植入器械上生物膜生长的抑制也归入同一范围。

• Additive manufacturing has a place as well, since three-dimensional printing now shapes porous scaffolds and patient-specific implants for the jaw and the hip.增材制造同样占有一席之地，三维打印如今用来成形多孔支架以及针对具体患者的颌骨与髋部植入物。

• Mechanical testing and wear, along with the long-term performance of a device, are treated as part of the application rather than an extra step.力学测试与磨损以及器械的长期性能被视为应用的一部分，不当作附加环节。

• Review articles are accepted alongside original papers, and a review is expected to cover a field rather than report a single experiment.综述与原创论文一并接收，综述需要覆盖一个领域，而不仅是报告单次实验。

• The scope closes on clinical use, so a materials paper with no route to a patient or a device sits at the edge of the journal.收稿范围的落点在临床应用，没有通往患者或器械路径的材料论文因此处在刊物的边缘。

History

• The first volume carried the year 1986 and came from Technomic Publishing, an independent technical house in Lancaster, Pennsylvania, that specialised in plastics and engineering books.第 1 卷标注的年份是 1986 年，出版方为 Technomic Publishing，一家位于宾夕法尼亚州兰开斯特的独立技术出版社，长于塑料与工程类图书。

• The National Library of Medicine still keeps that founding imprint in its catalogue record, with the city and the company named as they were.美国国立医学图书馆的编目记录至今保留这一创刊印记，城市与公司名称一仍其旧。

• From 2002 the title has been published from London by SAGE Publications, and the library's current imprint now dates from that year.自 2002 年起该刊转由 SAGE 在伦敦出版，图书馆的现行出版项即以那一年为起点。

• The publisher's editorial address is 1 Oliver's Yard, 55 City Road, London, the head office from which its journal list is run.出版方的编辑部地址是伦敦城市路 55 号奥利弗院 1 号，其期刊业务即在该总部运营。

• Crossref records show ten issues in each year from 2019 to 2025, and in 2020 numbers 4 and 5 were combined into one.Crossref 的记录显示 2019 年至 2025 年每年都是 10 期，2020 年第 4 期与第 5 期合为一册。

• Volume numbers have run without a break since 1986, and a single year can span several of them, as 2025 does with volumes 39 to 41.卷号自 1986 年起连续编号，未曾中断，一年之内可以跨过数卷，2025 年即从第 39 卷走到第 41 卷。

• The forty-first volume opened in 2026 and had reached its fifth number by the middle of that year.第 41 卷于 2026 年开始，到当年年中已出至第 5 期。

• Because ten issues are packed into volumes that change several times a year, each volume holds only a few numbers.10 期分摊在一年数换的卷次里，每卷只容纳少数几期。

• The print edition carries the number 0885-3282, and the electronic edition carries 1530-8022, which is the one most readers now use.印本刊号为 0885-3282，电子刊号为 1530-8022，后者是如今多数读者使用的版本。

• The National Library of Medicine abbreviates the title J Biomater Appl and has indexed it in MEDLINE from the first volume.美国国立医学图书馆把刊名缩写为 J Biomater Appl，并自第 1 卷起将其收入 MEDLINE。

• Index Medicus lists the title as well, and PubMed coverage likewise begins with the opening issue of 1986.Index Medicus 同样收录该刊，PubMed 的覆盖也自 1986 年首期开始。

• The 2025 Journal Impact Factor is 2.4 with a five-year figure of 2.6, and the title ranks 81 of 130 in biomedical engineering.2025 年影响因子为 2.4，五年影响因子为 2.6，在生物医学工程类目 130 种刊物中排第 81 位。

• In the materials science, biomaterials category it ranks 45 of 58, which puts it in the fourth quartile there.在材料科学的生物材料类目中它位列 58 种中的第 45 位，属于该类的第四象限。

• The same snapshot counts 3,666 citations, about 105 articles a year and a cited half-life of 6.7 years.同一份快照记录总被引 3666 次，年发文约 105 篇，被引半衰期为 6.7 年。

• Gold open access accounts for 7.28 percent of the output, so the title remains subscription based with an open option.金色开放获取占全部发文的 7.28%，该刊因此仍以订阅制为主，另设开放获取选项。

• The impact factor stood at 2.712 in 2022, fell to 2.3 in 2023, recovered to 2.5 in 2024 and settled at 2.4 in 2025.影响因子在 2022 年为 2.712，2023 年降至 2.3，2024 年回升到 2.5，2025 年落在 2.4。

Editors

• Jonathan Knowles, professor of biomaterials science at the Eastman Dental Institute, University College London, is the editor-in-chief and handles manuscripts from screening to final decision.Jonathan Knowles 是伦敦大学学院伊士曼牙科研究所的生物材料科学教授，担任该刊主编，从初筛到终裁都由他经手。

• His own work on calcium phosphate cements and bioactive glasses for bone repair sits close to the applied papers the journal prints.他本人的研究集中在骨修复用的磷酸钙骨水泥与生物活性玻璃，与该刊刊出的应用类论文相当接近。

• He also edits Journal of Tissue Engineering, another title in the SAGE list.他同时主编 SAGE 刊群中的另一份刊物《组织工程杂志》。

• The journal calls itself fully peer reviewed, and its guidelines say only manuscripts of sufficient quality and within scope are considered.该刊自称完全同行评审，投稿指南写明只有质量足够且落在范围之内的稿件才会进入考虑。

• Manuscripts, revisions included, are uploaded through ScholarOne Manuscript Central, at mc.manuscriptcentral.com/jba, where the editorial office tracks review.稿件与修改稿都通过 ScholarOne Manuscript Central 上传，编辑部在该系统里跟踪评审进程。

• The title is a member of the Committee on Publication Ethics and follows its guidance on misconduct, correction and retraction.该刊是出版伦理委员会的成员，按其指引处理学术不端、更正与撤稿。

• Reviewers come from the international research community, in line with the journal's own description of itself as an international outlet.评审人来自国际研究界，与该刊自述的国际性刊物身份相合。

• Where the scope is silent, the deciding question is whether a paper leads to a usable material, device or clinical procedure.收稿范围没有明说之处，判断标准落在论文能否通向可用的材料、器械或临床操作上。

• Accepted papers appear online first under a DOI, and are gathered into a numbered issue afterwards.录用的论文先以 OnlineFirst 形式凭 DOI 上线，随后汇编进编号的期次。

• Authors who take the open access option publish under a Creative Commons licence, while others sign the publisher's standard licence.选择开放获取的作者按知识共享许可发布，其余作者签署出版方的标准授权。

• Device-centred papers on dental and orthopaedic materials appear regularly, which reflects the applied emphasis the scope claims and the readership it serves.以牙科与骨科材料为对象的器械类论文定期出现，这与收稿范围自述的应用导向及其读者群相应。